sofinnova ventures News
Most Popular sofinnova ventures Story
KaloBios gains $20M in third round
KaloBios Pharmaceuticals has garnered $20 million in its third round, with much of that earmarked to advance its clinical development work. Lehman Brothers led the round with MPM Capital, Sofinnova... Read more...
Latest Headlines
- December 4, 2007
- September 6, 2007
- September 5, 2007
- July 23, 2007
- January 11, 2007
- September 20, 2006
- September 12, 2006
- September 11, 2006
- July 12, 2006
- January 3, 2006
- November 2, 2005
- October 24, 2005
Paid Research Reports
- RNA therapy: the next big thing after monoclonal antibodies?
- Biotech M&A Strategies: Deal assessments, trends and future prospects
- The Dermatology Market Outlook to 2013: Competitive landscape, pipeline analysis and growth opportunities
- Pipeline Insight: Cancer Overview - Breast, Gynecological, Genitourinary - Diverse drugs approaching the market for many tumor t
- Sales Force Effectiveness
